Skip to main content
Top

Seminars in Immunopathology

Issue 3/2021

Eosinophils

Content (13 Articles)

Intestinal eosinophils, homeostasis and response to bacterial intrusion

Alessandra Gurtner, Ignacio Gonzalez-Perez, Isabelle C. Arnold

Open Access Eosinophilic Esophagitis Review

Eosinophilic esophagitis—established facts and new horizons

Luc Biedermann, Alex Straumann, Thomas Greuter, Philipp Schreiner

Open Access Eosinophilic Disease Review

Regulation of eosinophil functions by autophagy

Nina Germic, Aref Hosseini, Shida Yousefi, Alexander Karaulov, Hans-Uwe Simon

Eosinophils in skin diseases

Susanne Radonjic-Hoesli, Marie-Charlotte Brüggen, Laurence Feldmeyer, Hans-Uwe Simon, Dagmar Simon

Eosinophils in the pathogenesis of pancreatic disorders

Murli Manohar, Hemanth Kumar Kandikattu, Sathisha Upparahalli Venkateshaiah, Chandra Sekhar Yadavalli, Anil Mishra

Open Access Eosinophilia Review

Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity

Peter Valent, Lina Degenfeld-Schonburg, Irina Sadovnik, Hans-Peter Horny, Michel Arock, Hans-Uwe Simon, Andreas Reiter, Bruce S. Bochner

Latest issues

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine